| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | yes | yes: 45 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 24 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 14 |
| NetGPI | no | yes: 0, no: 14 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0032991 | protein-containing complex | 1 | 11 |
| GO:1990904 | ribonucleoprotein complex | 2 | 11 |
| GO:0005634 | nucleus | 5 | 2 |
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0043226 | organelle | 2 | 2 |
| GO:0043227 | membrane-bounded organelle | 3 | 2 |
| GO:0043229 | intracellular organelle | 3 | 2 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 3 |
| GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: E9AXC6
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 15 |
| GO:0003723 | RNA binding | 4 | 15 |
| GO:0005488 | binding | 1 | 15 |
| GO:0097159 | organic cyclic compound binding | 2 | 15 |
| GO:1901363 | heterocyclic compound binding | 2 | 15 |
| GO:0003729 | mRNA binding | 5 | 2 |
| GO:0003730 | mRNA 3'-UTR binding | 6 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_MEL_PAP_1 | 55 | 61 | PF00089 | 0.351 |
| CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.325 |
| CLV_PCSK_PC1ET2_1 | 105 | 107 | PF00082 | 0.325 |
| CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.338 |
| CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.325 |
| DOC_CKS1_1 | 4 | 9 | PF01111 | 0.623 |
| DOC_CYCLIN_RxL_1 | 50 | 57 | PF00134 | 0.525 |
| DOC_MAPK_gen_1 | 105 | 111 | PF00069 | 0.525 |
| DOC_PP4_MxPP_1 | 5 | 8 | PF00568 | 0.645 |
| DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.656 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.687 |
| LIG_FHA_2 | 43 | 49 | PF00498 | 0.525 |
| LIG_IBAR_NPY_1 | 149 | 151 | PF08397 | 0.613 |
| LIG_LIR_Nem_3 | 57 | 62 | PF02991 | 0.525 |
| LIG_LIR_Nem_3 | 76 | 82 | PF02991 | 0.525 |
| LIG_SH2_CRK | 79 | 83 | PF00017 | 0.568 |
| LIG_SH2_STAT3 | 122 | 125 | PF00017 | 0.622 |
| LIG_SH2_STAT3 | 163 | 166 | PF00017 | 0.808 |
| LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.527 |
| LIG_SH3_3 | 24 | 30 | PF00018 | 0.699 |
| MOD_CK1_1 | 86 | 92 | PF00069 | 0.525 |
| MOD_CK2_1 | 43 | 49 | PF00069 | 0.525 |
| MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.694 |
| MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.325 |
| MOD_NEK2_1 | 111 | 116 | PF00069 | 0.675 |
| MOD_PKA_2 | 70 | 76 | PF00069 | 0.536 |
| MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.657 |
| TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.568 |
| TRG_Pf-PMV_PEXEL_1 | 53 | 57 | PF00026 | 0.325 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A1X0P4G4 | Trypanosomatidae | 65% | 83% |
| A0A1X0P4M7 | Trypanosomatidae | 67% | 100% |
| A0A3Q8ID53 | Leishmania donovani | 99% | 100% |
| A0A3S7WYY4 | Leishmania donovani | 100% | 100% |
| A0A422NWY7 | Trypanosoma rangeli | 72% | 100% |
| A4HDZ1 | Leishmania braziliensis | 90% | 100% |
| A4HDZ2 | Leishmania braziliensis | 90% | 100% |
| A4I191 | Leishmania infantum | 99% | 100% |
| E9AH94 | Leishmania infantum | 99% | 75% |
| E9AXC7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 100% | 100% |
| Q4QA45 | Leishmania major | 99% | 100% |
| Q4QA46 | Leishmania major | 99% | 100% |
| V5BNA6 | Trypanosoma cruzi | 70% | 100% |